Data from Phase 1b/2 trial presented at ESMO Breast Cancer 2026 further validate a biomarker-driven development strategy for evorpacept - - ...

Pharmacists play a vital role in oncology, enhancing patient care through medication management, education, and support for novel therapies. This episode discusses the critical role of pharmacists in ...

MEDSIR, an international company and a leader in oncology research, has presented the results of the PHERGain and PHERGain-2 ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Today we're going ...

"Zongertinib is setting a new standard as the first targeted therapy for treatment naïve patients with HER2-mutant advanced non-small cell lung cancer with demonstrated efficacy, a manageable safety ...

What Is Hyrnuo, and Why Does It Matter? Hyrnuo (sevabertinib) is a new oral medicine for adults with advanced nonsquamous non-small-cell lung cancer (NSCLC) carrying a specific genetic change known as ...

HER2-positive breast cancer is driven by HER2 protein overexpression, historically linked to poor outcomes but now improved by targeted therapies. Treatment varies by stage, involving surgery, ...

It seems there is no text provided for summarization. Please share the content you'd like summarized, and I'll be happy to help! Some clinicians are incorporating off-label HER2-targeted therapies in ...

HER2-positive metastatic biliary tract cancer (BTC) is a rare and aggressive cancer with limited treatment options Final results from the HERIZON-BTC-01 clinical trial, the largest study of a ...

—There was no significant difference in invasive disease-free survival between patients with human epidermal growth factor receptor 2-positive (HER2+) T1micN0 breast cancer who were and were not ...

If you or a loved one has lung cancer, you may be looking into treatment options. A new medicine you might hear about is Hernexeos (zongertinib). More specifically, Hernexeos is FDA-approved to treat ...

While receiving a metastatic cancer diagnosis can be overwhelming, it is important to keep in mind that not all cancers are ...